Notice concerning dissolution and liquidation of consolidated subsidiary
Filed with TSE · · 3 pages · English
Premier Anti-Aging Co., Ltd. (“the Company”) announces that at the Board of Directors meeting held on July 14, 2026, it has resolved to dissolve and liquidate its consolidated subsidiary, Premier Anti-Aging (Shanghai) Co., Ltd. (hereinafter “BAM”), as part of the structural reform of its China operations. 1. Rationale for dissolution and liquidation Since its establishment in 2021, BAM has been se
Premier Anti-Aging Co., Ltd. on 6ix
Earlier from Premier Anti-Aging
- Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending July 31, 2026
- Summary of Financial Results for the third quarter 2022
- Notice of Revision of Consolidated Earnings Forecasts for the Fiscal Year Ending July 31, 2022
- FY2022 3Q Results Briefing Material
- Premier Anti-Aging: This is an announcement regarding an exclusive license agreement with sublicensing rights of DDS technology DehydraTECH TM by the group company.
Later from Premier Anti-Aging
- Notice concerning future operations in China
- Consolidated Financial Results for the Fiscal Year Ended July 31, 2026
Follow Premier Anti-Aging into a list and get an email when it puts out news.
Follow Premier Anti-Aging